Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight in the COVID-19 era

Dermatol Ther. 2020 Jul;33(4):e13499. doi: 10.1111/dth.13499. Epub 2020 May 22.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antimalarials / adverse effects
  • Betacoronavirus*
  • COVID-19
  • COVID-19 Drug Treatment
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / epidemiology
  • Drug Hypersensitivity Syndrome / diagnosis*
  • Drug Hypersensitivity Syndrome / etiology
  • Eosinophilia / chemically induced
  • Eosinophilia / diagnosis*
  • Female
  • Humans
  • Hydroxychloroquine / adverse effects*
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / epidemiology
  • SARS-CoV-2

Substances

  • Antimalarials
  • Hydroxychloroquine